Radical radiotherapy for carcinoma of the prostate: localized and extended field treatment.
From 1972 to 1981, 50 patients who received radical radiotherapy for clinically localized adenocarcinoma of the prostate have been reviewed. Of these 50 patients, 70% showed some degree of reaction to the radiotherapy in the form of minor, transient urinary or bowel symptoms. Significant complications occurred in 20%, the most common of which was proctitis. There was no apparent relation of complication rate to the extent of the radiation field. The overall corrected 5 year survival was 74%.
D000230:Adenocarcinoma / Q000401:mortality / Q000532:radiotherapy*; D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D009367:Neoplasm Staging; D011349:Proctitis / Q000209:etiology; D011471:Prostatic Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000209:etiology; D013997:Time Factors